Evidence map›Paper›PMID 30319613›Full record

ReviewFrontiers in immunology2018

Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts.

Jonathan E Wosen, Dhriti Mukhopadhyay, Claudia Macaubas, Elizabeth D Mellins

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 154 papers.

0numbers the graph read from it
0cells of the map it votes in
154citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

154 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. T cell receptors for antigen on intraepithelial cytolytic T lymphocytes in celiac disease engage enterocyte HLA-E and HLA-B.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Oesophageal Epithelial Cell-Intrinsic MHCII Regulates Food Antigen-Dependent Eosinophilic Esophagitis in an IFNγ-Dependent Manner.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in immunology · 2026
    Article
  15. Article
  16. Silymarin Reduces the Inflammatory Response and the Burden ofInternational journal of microbiology · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Mucosal Responses to Type II Interferon in IBD.Inflammatory bowel diseases · 2025
    Article

94 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonathan E WosenProgram in Immunology, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Dhriti MukhopadhyayProgram in Immunology, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Claudia MacaubasProgram in Immunology, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Elizabeth D MellinsProgram in Immunology, Department of Pediatrics, Stanford University, Stanford, CA, United States.

Funding

Stanford/UNC Biomimetic U19 Research CenterU19AI116484 · NIAID · STANFORD UNIVERSITY · PI AMIEVA, MANUEL R, KUO, CALVIN J · 2015 to 2025
$13.5M
NIAID NIH HHS U19 AI116484
6 · The paper itself

Abstract

As the primary barrier between an organism and its environment, epithelial cells are well-positioned to regulate tolerance while preserving immunity against pathogens. Class II major histocompatibility complex molecules (MHC class II) are highly expressed on the surface of epithelial cells (ECs) in both the lung and intestine, although the functional consequences of this expression are not fully understood. Here, we summarize current information regarding the interactions that regulate the expression of EC MHC class II in health and disease. We then evaluate the potential role of EC as non-professional antigen presenting cells. Finally, we explore future areas of study and the potential contribution of epithelial surfaces to gut-lung crosstalk.

Indexed as

Antigen PresentationEpithelial CellsGastrointestinal MicrobiomeHistocompatibility Antigens Class IIHumansIntestinal MucosaLungRespiratory MucosaHistocompatibility Antigens Class IIantigen presentationepithelial cellsintestineMHC class IIrespiratory

Identifiers

PMID30319613
PMCPMC6167424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.